MBRX: Moleculin Biotech Inc

FinancialsDividends

$0.68

0.03

(5.25%)

As of 08/15/2025 5:00 PM ET • Disclaimer
Powered by Stocksift.com

100%

MBRX Performance Snapshot

1-Week Chg

1.19%

1-Month Chg

8.43%

3-Month Chg

-25.22%

6-Month Chg

-68.72%

1-Year Chg

-69.42%

Year-To-Date Chg

-61.47%

Beta 1-Year

2.05

Beta 5-Year

1.75

Volatility (10-Day)

2.85%

MBRX Technical Snapshot

Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-08-15

$0.68

$0.03 (5.25%)

$0.66

$0.69

$0.63

$0.67

743.00K ($506.73K)

2025-08-14

$0.65

-$0.03 (-4%)

$0.67

$0.67

$0.62

$0.65

678.00K ($439.34K)

2025-08-13

$0.68

$0.01 (1.96%)

$0.67

$0.69

$0.64

$0.67

988.00K ($666.90K)

2025-08-12

$0.66

$0.04 (6.43%)

$0.62

$0.66

$0.62

$0.65

609.00K ($403.16K)

2025-08-11

$0.62

-$0.05 (-7.72%)

$0.64

$0.67

$0.62

$0.64

913.00K ($567.89K)

2025-08-08

$0.67

-$0.00 (-0.44%)

$0.67

$0.68

$0.66

$0.67

571.00K ($384.85K)

2025-08-07

$0.68

$0.02 (3.2%)

$0.63

$0.68

$0.63

$0.66

626.00K ($423.80K)

2025-08-06

$0.66

-$0.03 (-4.09%)

$0.73

$0.73

$0.63

$0.67

3.18M ($2.09M)

2025-08-05

$0.68

-$0.00 (-0.29%)

$0.68

$0.71

$0.65

$0.68

826.00K ($564.98K)

2025-08-04

$0.69

$0.02 (3.16%)

$0.65

$0.70

$0.61

$0.67

1.60M ($1.10M)

MBRX Financial Snapshot

Balance Sheet

(USD)

2025 Q2

Y/Y CHANGE

  • Cash and equivalents

    $7.56M

    -30.32%

  • Total assets

    $21.59M

    -15.57%

  • Total liabilities

    $28.76M

    265.41%

  • Total investments

    $0

    0%

  • Shareholders' equity

    -$7.17M

    -140.47%

  • Book value per share

    -$0.46

    -106.62%

Income Statement

(USD)

2025 Q2

Y/Y CHANGE

  • Revenue

    $0

    0%

  • Net income

    -$7.64M

    -76.89%

  • Operating expense

    $5.72M

    -7.52%

  • Gross profit

    $0

    0%

  • EBITDA

    -$7.61M

    -77.52%

  • Earnings per share

    -$0.49

    71.18%

Cash Flow

(USD)

2025 Q2

Y/Y CHANGE

  • Net change in cash

    -$159.00K

    97.34%

  • Cash from operations

    -$5.58M

    6.17%

  • Cash from investing

    $0

    100.00%

  • Cash from financing

    $5.42M

    21792.00%

  • Free cash flow

    -$5.58M

    6.37%

  • Free cash flow per share

    -$0.36

    84.64%

Metrics

(USD)

2025 Q2

Y/Y CHANGE

  • Market capitalization

    $4.27M

    -47.58%

  • Enterprise value

    -$3.12M

    62.06%

  • Shares outstanding

    14.13M

    511.17%

  • Profit margin

    -

    -

  • Gross margin

    -

    -

  • EBITDA margin

    -

    -

Dividends

(USD)

2025 Q2

Y/Y CHANGE

  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    1.15

    -52.01%

View Financial Statements